Skip to content

Clinical trials

Phase 1/2 Emphysema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Phase 1/2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20092
20131
20141
20161
20171
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Suspended1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aeris Therapeutics2
Adverum Biotechnologies, Inc.1
Assaf-Harofeh Medical Center1
Boston Scientific Corporation1
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1
Grifols Therapeutics LLC1
Healeon Medical Inc1
Paul Szabolcs1
Pulmonx Corporation1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema11
Pulmonary Disease, Chronic Obstructive9
Lung Diseases4
Pulmonary Emphysema4
Pathologic Processes2
Respiratory Tract Diseases2
alpha 1-Antitrypsin Deficiency2
Bronchitis, Chronic1
Digestive System Diseases1
Genetic Diseases, Inborn1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.